Carl Zeiss Meditec AG (AFX) Given Consensus Rating of “Hold” by Analysts
Carl Zeiss Meditec AG (ETR:AFX) has been assigned a consensus recommendation of “Hold” from the seven analysts that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and three have given a buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is €45.75 ($54.46).
Several research analysts have recently issued reports on the company. Deutsche Bank AG set a €40.00 ($47.62) price target on Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a research note on Tuesday, August 8th. Kepler Capital Markets set a €48.50 ($57.74) price target on Carl Zeiss Meditec AG and gave the stock a “buy” rating in a research note on Monday, August 7th. Berenberg Bank set a €48.00 ($57.14) price target on Carl Zeiss Meditec AG and gave the stock a “buy” rating in a research note on Monday, August 7th. Commerzbank Ag set a €42.00 ($50.00) price target on Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a research note on Wednesday, August 2nd. Finally, Nord/LB set a €52.00 ($61.90) price target on Carl Zeiss Meditec AG and gave the stock a “buy” rating in a research note on Friday, June 2nd.
Shares of Carl Zeiss Meditec AG (AFX) opened at 42.68 on Friday. Carl Zeiss Meditec AG has a 12 month low of €30.80 and a 12 month high of €47.80. The stock has a market capitalization of €3.82 billion and a price-to-earnings ratio of 28.84. The firm’s 50 day moving average is €43.37 and its 200 day moving average is €43.25.
COPYRIGHT VIOLATION NOTICE: This story was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/09/09/carl-zeiss-meditec-ag-afx-given-consensus-rating-of-hold-by-analysts.html.
Carl Zeiss Meditec AG Company Profile
Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Receive News & Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related companies with MarketBeat.com's FREE daily email newsletter.